8-K
Current Report
Allarity Therapeutics, Inc. Filed Acc 0001213900-23-004263
Material agreement · Shareholder rights changed · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.03 Material modification to rights of security holders
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading ea172038-8k_allarity.htm…